What does Dr. Steinkamm Carsten do?

Dr. Steinkamm Carsten is a specialist medical practice in Antwerpen. Private Limited, started on 22 October 2004, 1 establishment.

What is the address of Dr. Steinkamm Carsten?

The registered office of Dr. Steinkamm Carsten is located at Gallaitlaan 303, 2610 Antwerpen.

Is Dr. Steinkamm Carsten still active?

Yes. According to the CBE (6 October 2026) Dr. Steinkamm Carsten is active, legal situation “Normale toestand”, started on 22 October 2004.

Is Dr. Steinkamm Carsten registered on Peppol?

Yes, Dr. Steinkamm Carsten is registered on the Peppol network with ID 0208:0869571940.

What is the enterprise number of Dr. Steinkamm Carsten?

The enterprise number of Dr. Steinkamm Carsten is BE0869571940.

When was Dr. Steinkamm Carsten founded?

Dr. Steinkamm Carsten was founded on 22 October 2004.

Who are the directors of Dr. Steinkamm Carsten?

According to the 2025 annual accounts, the directors of Dr. Steinkamm Carsten are: Carsten Steinkamm.

Is Dr. Steinkamm Carsten a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 October 2004; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Steinkamm Carsten make in 2025?

Dr. Steinkamm Carsten posted a profit after taxes of € 149,014 in financial year 2025.

What is the revenue of Dr. Steinkamm Carsten?

As a small company, Dr. Steinkamm Carsten is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 286,258.

Dr. Steinkamm Carsten (Private Limited) - Antwerpen

Dossier Dr. Steinkamm Carsten, printed on 6 October 2026 from databakkes.be/en/0869571940/dr-steinkamm-carsten. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Steinkamm Carsten from Antwerpen, company number BE0869571940, closed financial year 2025 with a result of € 149,014 after tax. For that financial year Dr. Steinkamm Carsten recorded a gross margin of € 286,258 and equity of € 622,113. Compared with financial year 2024, the result moved from € 89,874 to € 149,014. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 622,113

▼ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 149,014

▲ 66% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 44,064

▼ 37% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 260,205 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 27,460

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 408,432

▲ 92% vs 2024

€ 110,740 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 9,751

▲ 48% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,825

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 309,482 Gross margin 2022: € 309,482 First fiscal year in the series	€ 232,850 Gross margin 2023: € 232,850 ▼ 25% vs 2022 (€ 309,482) Unfavourable step	€ 226,354 Gross margin 2024: € 226,354 ▼ 3% vs 2023 (€ 232,850) Unfavourable step	€ 286,258 Gross margin 2025: € 286,258 ▲ 26% vs 2024 (€ 226,354) Favourable step	▲ 26%
Profit after taxes	€ 168,638 Profit after taxes 2022: € 168,638 First fiscal year in the series	€ 110,867 Profit after taxes 2023: € 110,867 ▼ 34% vs 2022 (€ 168,638) Unfavourable step	€ 89,874 Profit after taxes 2024: € 89,874 ▼ 19% vs 2023 (€ 110,867) Unfavourable step	€ 149,014 Profit after taxes 2025: € 149,014 ▲ 66% vs 2024 (€ 89,874) Favourable step	▲ 66%
Equity	€ 643,209 Equity 2022: € 643,209 First fiscal year in the series	€ 707,896 Equity 2023: € 707,896 ▲ 10% vs 2022 (€ 643,209) Favourable step	€ 733,304 Equity 2024: € 733,304 ▲ 4% vs 2023 (€ 707,896) Favourable step	€ 622,113 Equity 2025: € 622,113 ▼ 15% vs 2024 (€ 733,304) Unfavourable step	▼ 15%
Total debts	€ 342,873 Total debts 2022: € 342,873 First fiscal year in the series	€ 279,842 Total debts 2023: € 279,842 ▼ 18% vs 2022 (€ 342,873) Favourable step	€ 219,839 Total debts 2024: € 219,839 ▼ 21% vs 2023 (€ 279,842) Favourable step	€ 436,008 Total debts 2025: € 436,008 ▲ 98% vs 2024 (€ 219,839) Unfavourable step	▲ 98%
Cash	€ 202,770 Cash 2022: € 202,770 First fiscal year in the series	€ 67,408 Cash 2023: € 67,408 ▼ 67% vs 2022 (€ 202,770) Unfavourable step	€ 70,039 Cash 2024: € 70,039 ▲ 4% vs 2023 (€ 67,408) Favourable step	€ 44,064 Cash 2025: € 44,064 ▼ 37% vs 2024 (€ 70,039) Unfavourable step	▼ 37%
Land & buildings	€ 611,115 Land & buildings 2022: € 611,115 First fiscal year in the series	€ 598,203 Land & buildings 2023: € 598,203 ▼ 2% vs 2022 (€ 611,115) Unchanged	€ 526,944 Land & buildings 2024: € 526,944 ▼ 12% vs 2023 (€ 598,203) Unchanged	€ 477,372 Land & buildings 2025: € 477,372 ▼ 9% vs 2024 (€ 526,944) Unchanged	▼ 9%
Retained profit	€ 630,809 Retained profit 2022: € 630,809 First fiscal year in the series	€ 695,496 Retained profit 2023: € 695,496 ▲ 10% vs 2022 (€ 630,809) Favourable step	€ 714,704 Retained profit 2024: € 714,704 ▲ 3% vs 2023 (€ 695,496) Favourable step	€ 603,513 Retained profit 2025: € 603,513 ▼ 16% vs 2024 (€ 714,704) Unfavourable step	▼ 16%
Dividend	€ 137,862 Dividend 2022: € 137,862 First fiscal year in the series	€ 46,179 Dividend 2023: € 46,179 ▼ 67% vs 2022 (€ 137,862) Unchanged	€ 70,665 Dividend 2024: € 70,665 ▲ 53% vs 2023 (€ 46,179) Unchanged	€ 260,205 Dividend 2025: € 260,205 ▲ 268% vs 2024 (€ 70,665) Unchanged	▲ 268%
Bank debt	€ 283,798 Bank debt 2022: € 283,798 First fiscal year in the series	€ 273,010 Bank debt 2023: € 273,010 ▼ 4% vs 2022 (€ 283,798) Favourable step	€ 213,248 Bank debt 2024: € 213,248 ▼ 22% vs 2023 (€ 273,010) Favourable step	€ 408,432 Bank debt 2025: € 408,432 ▲ 92% vs 2024 (€ 213,248) Unfavourable step	▲ 92%
Balance sheet total	€ 986,082 Balance sheet total 2022: € 986,082 First fiscal year in the series	€ 987,738 Balance sheet total 2023: € 987,738 Unchanged (€ 986,082) Unchanged	€ 953,143 Balance sheet total 2024: € 953,143 ▼ 4% vs 2023 (€ 987,738) Unchanged	€ 1,058,121 Balance sheet total 2025: € 1,058,121 ▲ 11% vs 2024 (€ 953,143) Unchanged	▲ 11%

Key figures of Dr. Steinkamm Carsten, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Steinkamm Carsten?

What happened at Dr. Steinkamm Carsten in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 149,014 (▲ 66% vs 2024). filed late Source: NBB ↗
Oct 22, 2004 Start of the company according to the CBE. KBO
Oct 21, 2004 New establishment in Antwerpen. KBO

In short

From € 168,638 profit in 2022 to € 149,014 profit in 2025.

Paid € 223,328 in corporate taxes since 2022.

Best year ever: 2022, with € 168,638 profit.

Paid out € 514,912 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Steinkamm Carsten? We notify you, reason included.

Follow Dr. Steinkamm Carsten

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Carsten Steinkamm

Dr. Steinkamm Carsten

Behind Dr. Steinkamm Carsten is Carsten Steinkamm.

See the full network in the app

Directors

According to the 2025 annual accounts

Carsten Steinkamm

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Gallaitlaan 303

2610 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0869.571.940
VAT number: BE 0869.571.940
Registered office: Gallaitlaan 303, 2610 Antwerpen
Names & denominations: Dr. Steinkamm Carsten
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 October 2004
Peppol: Active · Active since 9 Oct 2024
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗